External Quality Assurance in Genetics Laboratories
|
|
- Sydney McBride
- 5 years ago
- Views:
Transcription
1 Genetics Quality and Accreditation workshop External Quality Assurance in Genetics Laboratories Farrah Khawaja Deputy Scheme Director UK NEQAS for Molecular Genetics The Royal Infirmary of Edinburgh
2 Molecular Pathology Monogenic diseases EQAs New born screening EQAs Next Generation Sequencing pilot Preimplantation Genetic Diagnosis Non-invasive prenatal testing pilot 100K Genomes project EQAs Tumour Assessment Training/ Competency Molecular Rapid Aneuploidy testing EQA
3 Monogenic diseases EQAs Frequency: Annually No. of EQAs: 28 inherited disorders Assessment: Genotyping Interpretation Clerical Accuracy Routine Testing New born screening EQAs Frequency: Quarterly No. of EQAs: - CF - MCAAD Assessment: Genotyping only
4 Preimplantation Genetic Diagnosis Frequency: Annually No. of EQAs: 4 full PGD schemes Assessment: Genotyping Interpretation Clerical Accuracy PGD for Monogenic Disorders 2017: CF Two Stage EQA - Stage 1 Feasibility study testing DNA samples - Stage 2 Single cell testing/embryo testing PGD Blastomere/Trophectoderm Array/NGS - Aneuploidy - Chromosome rearrangement - Polar Body In Collaboration with CEQAS
5 Non-invasive prenatal testing pilot Frequency: Annually No. of EQAs: 1 (pilot) Assessment: Genotyping Only NIPT for aneuploidies testing Chromosomes 13, 18 and 21 In Collaboration with CEQAS and EMQN
6 Molecular Rapid Aneuploidy testing EQA Frequency: Annually No. of EQAs: 1 Assessment: Genotyping Interpretation Clerical Accuracy Rapid aneuploidy testing Chromosomes 13, 18 and 21 In Collaboration with CEQAS
7 Molecular Pathology Frequency: Annually No. of EQAs: 6 Frequency: Bi-annually No. of EQAs: - Colorectal Cancer - Lung Cancer - Melanoma Assessment: Genotyping Interpretation Clerical Accuracy Assessment: Genotyping & Interpretation - MSI testing (inc BRAF & MLH1 promoter methylation) - Sarcoma testing (In Collaboration with CEQAS) - BRCA testing in ovarian cancer somatic & germline (pilot) (In Collaboration with EMQN) Assessment: Genotyping only - Gastro-Intestinal Stromal Tumours (GIST) - Molecular Tissue identification (pilot) - Additional lung biomarkers (ROS1, RET and MET) Circulating Tumour Frequency: Annually No. of EQAs: 1 Assessment: Genotyping only IQNPath pilot with EMQN, AIOM, ESP
8 TECHNICAL EQAS Next Generation Sequencing pilot Frequency: Annually No. of EQAs: - Germline - Somatic (In Collaboration with EMQN) 100K Genomes project EQAs Frequency: Annually No. of EQAs: - DNA extraction from Blood - DNA extraction from FFPE - DNA extraction from FF tissue (pilot) - DNA extraction from Saliva (pilot) - DNA quality measurement (pilot)
9 ONLINE EQAS Tumour Assessment Training/ Competency
10 EQA Histopathology tissue assessment for molecular testing Range of tissue types covered Mark regions of tumour appropriate for macrodissection for molecular testing Estimate the cellularity & percentage of neoplastic nuclei across the slide image and within the annotated region Collaborating with PathXL NHS England funded for NHS Genomic Medicine Centres
11 Tissue-I EQA Genetics Training Assessment and Competency Tool
12 Tissue-I EQA Sample Reception Report authorisation Duty Scientist Data analysis
13 Tissue-I EQA Genomics Training modules Cytogenetics Molecular Pathology Variant interpretation
14 Tissue-I EQA
15 Tissue-I EQA Laboratory based Clinician based Interactive Click on in tray to view samples Or the door to leave
16 Tissue-I EQA Sample Reception Module
17 Tissue-I EQA Sample Reception Module Recognition of correct test Assigning appropriate priority
18 Tissue-I EQA Variant Assessment Module
19 Tissue-I EQA Variant Assessment Module
20 Tissue-I EQA Participation Dashboard Flexibility to complete scenarios at a later date
21 Tissue-I EQA Demonstrate competency or identify any errors
22 Tissue-I EQA Line manager can view results for all TACT users
23 Tissue-I EQA Line managers can view all details entered by individuals. The visual data field can be used to view the request card and label for each referral given in a scenario.
24 Tissue-I EQA Leave individual feedback Perform periodic review of staff Override results based on local practice
25 Number of participations Number of laboratories Number of EQA schemes Participant numbers 2016 Number of EQA Schemes Number of Laboratories 500 EQA year Number of Participations EQA year EQA year
26 Scheme Activity Countries Continent No. of Labs Europe - UK 102 Europe - Non-UK 288 Africa 16 Asia 64 Australasia 16 North America 34 South America 39 TOTAL % 3% Number of Labs per Continent 6% 3% 7% 18% Europe - UK Europe - Non-UK Africa Asia Australasia North America South America 52%
27 Participant meetings Participants meeting 2017 May at ESHG - NIPT, Copenhagen, Denmark
28 Participant meetings Participants meeting 2017 May at ESHG - NIPT, Copenhagen, Denmark 2. UK NEQAS for Molecular Genetics Participants meeting 2017 June at ACGS, Birmingham
29 Acknowledgements The development of this training assessment and competency tool has been partly supported by a grant from Health Education England. Director: Dr Sandi Deans UK NEQAS for Molecular Genetics Team Specialist Advisory Groups
30 What do you want?
Genetics Quality and Accreditation workshop Manchester 17 th May 2017
Genetics Quality and Accreditation workshop Manchester 17 th May 2017 Katrina Rack Oxford CEQAS What is CEQAS Types of schemes Scheme update Highlights 2016 Key recommendations CEQAS Background External
More informationCollaboration between CEQAS and UK NEQAS for Molecular Genetics Solid Tumour EQAs and variant interpretation
Collaboration between CEQAS and UK NEQAS for Molecular Genetics Solid Tumour EQAs and variant interpretation Dr Jenni Fairley Deputy Scheme Director (Molecular Pathology), GenQA, Edinburgh, UK From 1 st
More informationNational Quality Assurance Advisory Panel - Genetics
National Quality Assurance Advisory Panel - Genetics Annual Report 2015-16 Meetings The Panel met twice during this period (30th March 2015 and 5th October 2015) with this frequency of meetings set to
More informationNational Quality Assurance Advisory Panel - Genetics
National Quality Assurance Advisory Panel - Genetics Annual Report 2011-12 Meetings The Panel met twice during this period (18th October 2011 and 26 th March 2012) with this frequency of meetings to continue
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK University Hospitals NHS Foundation Trust, Level 1, The Women s Centre John Radcliffe Hospital University Hospitals NHS Foundation Trust OX3
More informationOrganisation of the PGD Centre. Overview. Setting up a PGD centre
Organisation of the PGD Centre Joyce Harper Chair of the ESHRE PGD Consortium Overview Setting up a PGD Centre Organisation of the PGD Centre Preparation for clinical PGD Misdiagnosis Accreditation External
More informationOrganisation of the PGD Centre
Organisation of the PGD Centre Joyce Harper Chair of the ESHRE PGD Consortium Overview Setting up a PGD Centre Organisation of the PGD Centre The patient Workup PGD cycle Misdiagnosis Accreditation EQA
More informationThe Cancer Research UK Stratified Medicine Programme: Phases One and Two Dr Emily Shaw
The Cancer Research UK Stratified Medicine Programme: Phases One and Two Dr Emily Shaw Introduction The CRUK Stratified Medicine Programme: SMP1 rationale, design and implementation The role of the cellular
More informationMolecular blood spot performance monitoring
Molecular blood spot performance monitoring Description This management procedure document details the processes involved in determining the performance standard of each participating laboratory in the
More informationGenetic testing in Europe: a network for test development, harmonization, validation and standardization of services
Genetic testing in Europe: a network for test development, harmonization, validation and standardization of services Capability 1st Workshop, Trollenholm Sweden, May 7-9, 2007 Milan Macek Charles University,
More informationThe use of diagnostic FFPE material in cancer epidemiology research
The use of diagnostic FFPE material in cancer epidemiology research Neil O Callaghan Genetic Epidemiology Laboratory Department of Pathology The University of Melbourne www.pedigree.org.au Overview Who
More information4th Central Eastern European Symposium on Free Nucleic Acids in Non-Invasive Prenatal Diagnosis Split, May Second Announcement
Josip Juraj Strossmayer University of Osijek FACULTY OF MEDICINE OSIJEK 4th Central Eastern European Symposium on Free Nucleic Acids in Non-Invasive Prenatal Diagnosis Split, 25-26 May 2016 Second Announcement
More informationYour Health Topic : Genomics and Clinical Practice How genetics is improving care for patients
Your Health Topic : Genomics and Clinical Practice How genetics is improving care for patients Speaker Dr Kevin Monahan FRCP PhD Consultant Gastroenterologist, Family History of Bowel Cancer Clinic, Chelsea
More informationWhat is ERNDIM? Brian Fowler, Basel / Zürich, Switzerland. Brian Fowler University Children's Hospital Basel & Zürich, Switzerland
What is ERNDIM? Brian Fowler, Basel / Zürich, Switzerland Brian Fowler University Children's Hospital Basel & Zürich, Switzerland What is ERNDIM? Origins of ERNDIM, a bit of history Our aims and philosophy
More informationQA Processes. Philip DaCosta BSCP QA Lead, Yorkshire & the Humber September 2013
QA Processes Philip DaCosta BSCP QA Lead, Yorkshire & the Humber September 2013 Standards QA visits Dashboards BCSP standards Standards for Organisation Service delivery Reporting Data quality Audit and
More informationPersonalised cancer care Information for Medical Specialists. A new way to unlock treatment options for your patients
Personalised cancer care Information for Medical Specialists A new way to unlock treatment options for your patients Contents Optimised for clinical benefit 4 Development history 4 Full FIND IT panel vs
More informationDr Yvonne Wallis Consultant Clinical Scientist West Midlands Regional Genetics Laboratory
Dr Yvonne Wallis Consultant Clinical Scientist West Midlands Regional Genetics Laboratory Personalised Therapy/Precision Medicine Selection of a therapeutic drug based on the presence or absence of a specific
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
Building 9 Contact: Dr Catherine Sturgeon BioQuarter Tel: +44 (0)131-2426885 Little France Road Fax: +44 (0)131-242-6882 E-Mail: c.sturgeon@ed.ac.uk Websites: http://edqas.org EH16 4UX Proficiency Testing
More informationColorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital
Colorectal Cancer - Working in Partnership David Baty Genetics, Ninewells Hospital Genetics and Pathology National initiatives Colorectal cancer Inherited CRC Sporadic CRC The Liquid Biopsy The future?
More informationWHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.
WHAT IS A GENE? CHROMOSOME GENE DNA A gene is made up of DNA. It carries instructions to make proteins. The proteins have specific jobs that help your body work normally. PROTEIN 1 WHAT HAPPENS WHEN THERE
More informationPractical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs
Practical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs Joris Vermeesch, Center for Human Genetics K.U.Leuven, Belgium ESHG June 11, 2010 When and
More informationIntroduction to Quality Management Systems
Introduction to Quality Management Systems Prof dr Elisabeth Dequeker UZ-KULeuven, Belgium 1 Agenda Assessing Quality in a PGD laboratory Quality standards and accreditation Quality Management Systems
More informationOut-Patient Billing CPT Codes
Out-Patient Billing CPT Codes Updated Date: August 3, 08 Client Billed Molecular Tests HPV DNA Tissue Testing 8764 No Medicare Billed - Molecular Tests NeoARRAY NeoARRAY SNP/Cytogenetic No 89 NeoLAB NeoLAB
More informationyour guide to PGD Preimplantation Genetic Diagnosis Clinical excellence & bespoke fertility care
your guide to PGD Preimplantation Genetic Diagnosis Clinical excellence & bespoke fertility care CRGH Since 1990, The Centre for Reproductive & Genetic Health (CRGH) has been offering clinical excellence
More informationDiagnostics guidance Published: 22 February 2017 nice.org.uk/guidance/dg27
Molecular testing strategies for Lynch syndrome in people with colorectal cancer Diagnostics guidance Published: 22 February 2017 nice.org.uk/guidance/dg27 NICE 2018. All rights reserved. Subject to Notice
More informationSpecialised Services - Standards and Quality
Specialised Services - Standards and Quality Clinical Assurance Aim: to seek to provide assurance that the products of commissioning have clinical support from as broad a range of sectors and services
More informationMolecular Diagnostics Centre
Directorate of Central Manchester Haematology Service Molecular Diagnostics Centre Haemato-Oncology User Guide 2014 Page 1 of 13 Directorate of CONTENTS About Us 3 Contact Details 3 Location 3 Postal Address
More informationThe 100,000 Genomes Project
The 100,000 Genomes Project Dr Matina Prapa, Scientific co ordinator Genomics England Clinical Interpretation Partnership William Harvey Research Institute Queen Mary University of London Genomics England
More informationNeoTYPE Cancer Profiles
NeoTYPE Cancer Profiles Multimethod Analysis of 25+ Hematologic Diseases and Solid Tumors Anatomic Pathology FISH Molecular The next generation of diagnostic, prognostic, and therapeutic assessment NeoTYPE
More informationWHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.
WHAT IS A GENE? CHROMOSOME E GEN DNA A gene is made up of DNA. It carries instructions to make proteins. The proteins have specific jobs that help your body work normally. PROTEIN 1 WHAT HAPPENS WHEN THERE
More informationTGL clinical User Guide
TGL clinical User Guide The Institute of Cancer Research Brookes Lawley Building 15 Cotswold Road Sutton, Surrey SM2 5NG Page 1 of 7 TGL clinical This document describes the services provided by TGL clinical
More informationResource impact report: Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27)
Putting NICE guidance into practice Resource impact report: Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27) Published: February 2017 Summary Molecular testing strategies
More informationHow close are we to standardised extended RAS gene mutation testing? The UK NEQAS experience
How close are we to standardised extended RAS gene mutation testing? The UK NEQAS experience Dr Susan D. Richman, Dr Jennifer Fairley, Dr Rachel Butler, Dr Zandra C. Deans Overview Introduction to UK NEQAS
More informationCurrent and future applications of Molecular Pathology. Kathy Walsh Clinical Scientist NHS Lothian
Current and future applications of Molecular Pathology Kathy Walsh Clinical Scientist NHS Lothian Molecular Pathology in Solid tumours Cancer type Genes tested Purpose Associated treatments Non small cell
More informationDIAGNOSTICS ASSESSMENT PROGRAMME Diagnostics consultation document
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE DIAGNOSTICS ASSESSMENT PROGRAMME Diagnostics consultation document Molecular testing strategies for Lynch syndrome in The National Institute for Health
More informationImplementation of nation-wide molecular testing in oncology in the French Health care system : quality assurance issues & challenges
Implementation of nation-wide molecular testing in oncology in the French Health care system : quality assurance issues & challenges Frédérique Nowak - 21 october 2015 "Putting Science into Standards event:
More informationSPECIALIST REGISTRAR PAEDIATRIC HISTOPATHOLOGY JOB DESCRIPTION. Page 1 of 10
SPECIALIST REGISTRAR IN PAEDIATRIC HISTOPATHOLOGY JOB DESCRIPTION SEPTEMBER 2011 Page 1 of 10 THE CENTRAL MANCHESTER UNIVERSITY NHS FOUNDATION TRUST - ROYAL MANCHESTER CHILDREN S HOSPITAL DEPARTMENT OF
More informationCancer Waiting Times. 1 April Adjuvant Radical External Beam Radiotherapy Definitions. Version 1.0
Cancer Waiting Times Adjuvant Radical External Beam Radiotherapy Definitions Version 1.0 1 April 2015 Document Control Document Purpose Definitions for NHS Boards for the adjuvant radical external beam
More informationGuidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer
Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer Start date: May 2015 Review date: April 2018 1 Background Mismatch repair (MMR) deficiency is seen in approximately 15%
More information100,000 genomes RD Validation and Reporting Working Groups - Overview - Dom McMullan Chair Association for Clinical Genomic Science
100,000 genomes RD Validation and Reporting Working Groups - Overview - Dom McMullan Chair Association for Clinical Genomic Science What? More Working Groups? Post January 20 th meeting Volunteers for
More informationThe Application of Digital Morphology in Haematology Education. Barbara De la Salle Deputy Director UK NEQAS General Haematology
The Application of Digital Morphology in Haematology Education Barbara De la Salle Deputy Director UK NEQAS General Haematology 8 November, 2011 UK National External Quality Assessment Service comprises
More informationCOLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer
COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer January 2015 1 Background Mismatch repair (MMR) deficiency is seen in approximately
More informationDevelopments in Laboratory Genetics
Developments in Laboratory Genetics Rachel Butler rachel.butler@wales.nhs.uk The Impact of Genomics on Public Health Where are we now? Single gene disorders Core disorders Newborn screening (CF, MCAD)
More informationAugust 17, Dear Valued Client:
August 7, 08 Re: CMS Announces 6-Month Period of Enforcement Discretion for Laboratory Date of Service Exception Policy Under the Medicare Clinical Laboratory Fee Schedule (the 4 Day Rule ) Dear Valued
More informationCancer Validation in the 100,000 genomes project. Dr Shirley Henderson ACGS spring meeting 06/07/16
Cancer Validation in the 100,000 genomes project Dr Shirley Henderson ACGS spring meeting 06/07/16 Cancer is a lesion of the Genome Diagnosis Cancer Molecular Lesions Prognosis Disease Monitoring Why is
More informationOverview of the ESP Lung and Colon EQA schemes with a focus on Dutch laboratories
Overview of the ESP Lung and Colon EQA schemes with a focus on Dutch laboratories Dr. Nils t Hart University Medical Center Groningen, The Netherlands Drs. Cleo Keppens Catholic University of Leuven, Belgium
More informationPreimplantation genetic diagnosis
Preimplantation genetic diagnosis Borut Peterlin Clinical institute of medical genetics, University Medical Centre Ljubljana Outline of the presentation Primary prevention of genetic diseases Motivation
More informationNotes for slide 2 Welcome to today s training webinar. We appreciate everyone taking time today to hear our presentations. We are very excited to fina
Notes for slide 2 Welcome to today s training webinar. We appreciate everyone taking time today to hear our presentations. We are very excited to finally be able to put these genomics related data items
More informationCOLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer
COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer March 2017 1 Background Mismatch repair (MMR) deficiency is seen in approximately
More informationMolecular. Oncology & Pathology. Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine. Liquid Biopsy.
Molecular Oncology & Pathology Hereditary Cancer Somatic Cancer Liquid Biopsy Next-Gen Sequencing qpcr Sanger Sequencing Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine
More informationInformation for You and Your Family
Information for You and Your Family What is Prevention? Cancer prevention is action taken to lower the chance of getting cancer. In 2017, more than 1.6 million people will be diagnosed with cancer in the
More informationPutting NICE guidance into practice
Putting NICE guidance into practice Resource impact report: Olaparib for maintenance treatment of relapsed, platinum-sensitive, BRCA mutation-positive ovarian, fallopian tube and peritoneal cancer after
More informationDeveloping effective ctdna testing services for lung cancer. Executive summary
Developing effective ctdna testing services for lung cancer Executive summary September 2017 Authors: Laura Blackburn, Leila Luheshi, Sandi Deans, Mark Kroese, Hilary Burton Acknowledgements: The PHG Foundation
More informationpat hways Medtech innovation briefing Published: 20 September 2017 nice.org.uk/guidance/mib120
pat hways Caris Molecular Intelligence for guiding cancer treatment Medtech innovation briefing Published: 20 September 2017 nice.org.uk/guidance/mib120 Summary The technology described in this briefing
More informationThe 100,000 Genomes Project Harnessing the power of genomics for NHS rare disease and cancer patients
The 100,000 Genomes Project Harnessing the power of genomics for NHS rare disease and cancer patients Dr Richard Scott, Clinical Lead for Rare Disease Dr Nirupa Murugaesu, Clinical Lead for Cancer Four
More informationIntegration of Cancer Genome into GECCO- Genetics and Epidemiology of Colorectal Cancer Consortium
Integration of Cancer Genome into GECCO- Genetics and Epidemiology of Colorectal Cancer Consortium Ulrike Peters Fred Hutchinson Cancer Research Center University of Washington U01-CA137088-05, PI: Peters
More informationMOLECULAR DIAGNOSTIC PROVISION IN WALES
MOLECULAR DIAGNOSTIC PROVISION IN WALES FOR TARGETED CANCER MEDICINES (SOLID TUMOUR) IN THE NHS A report for Cancer Research UK by Concentra September 2015 Molecular diagnostic provision in the NHS in
More informationData briefing: Reflex testing for Lynch syndrome in people diagnosed with bowel cancer under the age of 50
Data briefing: Reflex testing for Lynch syndrome in people diagnosed with bowel cancer under the age of 50 Introduction Lynch syndrome is an inherited condition that predisposes individuals to bowel and
More informationSession 4 Rebecca Poulos
The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 20
More informationLYNCH SYNDROME: IN YOUR FACE BUT LOST IN SPACE (MOUNTAIN)!
LYNCH SYNDROME: IN YOUR FACE BUT LOST IN SPACE (MOUNTAIN)! Kathryn Singh, MPH, MS, LCGC Associate Clinical Professor Assistant Director, Graduate Program in Genetic Counseling Division of Genetic and Genomic
More information21 st Century Slide Based Pathology & Molecular Diagnostics: From the Laboratory to the Patient
A meeting hosted by at The Tower Hotel Conference Centre St Katharine's Way, London E1W 1LD 21 st Century Slide Based Pathology & Molecular Diagnostics: From the Laboratory to the Patient For Registration
More information100,000 Genomes Project Update: The Cancer Programme Cancer Testing Strategy & NHS Genomic Medicine Service
100,000 Genomes Project Update: The Cancer Programme Cancer Testing Strategy & NHS Genomic Medicine Service Nirupa Murugaesu Consultant Medical Oncologist at St George s Hospital Clinical Lead for Molecular
More informationIntroduction to liquid biopsies. Rachel Butler All Wales Genetics Laboratory
Introduction to liquid biopsies Rachel Butler All Wales Genetics Laboratory What is cell free DNA? Non-Invasive Prenatal Testing (NIPT) Extract DNA Genetic alterations detectable in circulating cell-free
More informationClinical Cytogenetics September 14 th 20 th, 2014 Goldrain, South Tyrol, Italy
Thanks for their support to: E.C.A. European Cytogeneticists Association Clinical Cytogenetics September 14 th 20 th, 2014 Goldrain, South Tyrol, Italy DIRECTOR: A. Schinzel (Zurich, Switzerland) FACULTY:
More informationSession 4 Rebecca Poulos
The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 28
More informationGenetic counselling in PGD
Genetic counselling in PGD Sérgio Castedo Serviço de Genética Faculdade de Medicina do Porto scastedo@netcabo.pt Disclosure of interests Sérgio Castedo is the CEO of GDPN, a private genetics diagnostic
More informationVersion 2 of these Guidelines were drafted in response to published updated ASCO/CAP HER2 test Guideline Recommendations-
Introduction: These guidelines represent systematically developed statements to assist in the provision of quality assured HER2 testing in breast and gastric/ gastro-oesophageal carcinoma. They are based
More informationNeoTYPE Cancer Profiles
NeoTYPE Cancer Profiles 30+ Multimethod Assays for Hematologic Diseases and Solid Tumors Molecular FISH Anatomic Pathology The next generation of diagnostic, prognostic, and therapeutic assessment What
More informationPolicy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014
Medical Policy Genetic Testing for Colorectal Cancer Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Laboratory/Pathology Original Policy Date: Effective Date: October
More informationCase scenarios: Patient Group Directions
Putting NICE guidance into practice Case scenarios: Patient Group Directions Implementing the NICE guidance on Patient Group Directions (MPG2) Published: March 2014 [updated March 2017] These case scenarios
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Genetic Causes of Hypothyroidism 1. Loss of function mutations in TSHR cause thyroid
More information5 th July 2016 ACGS Dr Michelle Wood Laboratory Genetics, Cardiff
5 th July 2016 ACGS Dr Michelle Wood Laboratory Genetics, Cardiff National molecular screening of patients with lung cancer for a national trial of multiple novel agents. 2000 NSCLC patients/year (late
More informationGenetics in Primary Care: An Update
Genetics in Primary Care: An Update September 11, 2018 Jagdeep S Walia, MBBS, FRCPC, FCCMG Head, Division of Medical Genetics, Director of Research, Department of Pediatrics, Queen s University Financial
More informationColorectal cancer: pathology
UK NEQAS for Molecular Pathology Colorectal cancer: pathology Nick West Pathology & Tumour Biology May 2013 Colorectal cancer (CRC) 40,695 new cases in 2010 15,708 deaths Management of CRC Surgery Main
More informationB Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696
Index Note: Page numbers of article titles are in boldface type. A Adenomatous polyposis, familial. See Familial adenomatous polyposis. Anal anastomosis, ileal-pouch, proctocolectomy with, in FAP, 591
More informationLynch Syndrome. Angie Strang, PGY2
Lynch Syndrome Angie Strang, PGY2 Background Previously hereditary nonpolyposis colorectal cancer Autosomal dominant inherited cancer susceptibility syndrome Caused by defects in the mismatch repair system
More informationTransform genomic data into real-life results
CLINICAL SUMMARY Transform genomic data into real-life results Biomarker testing and targeted therapies can drive improved outcomes in clinical practice New FDA-Approved Broad Companion Diagnostic for
More informationThe Next Generation of Hereditary Cancer Testing
The Next Generation of Hereditary Cancer Testing Why Genetic Testing? Cancers can appear to run in families. Often this is due to shared environmental or lifestyle patterns, such as tobacco use. However,
More informationSpecialised Services Service Specification: CP99 Genetic Services
Specialised Services CP99 Genetic Services Document Author: Assistant Specialised Planner Executive Lead: Director of Planning Approved by: Management Group Issue Date: 01 March 2016 Review Date: March
More informationTechnology appraisal guidance Published: 28 March 2018 nice.org.uk/guidance/ta516
Cabozantinib for treating medullary thyroid cancer Technology appraisal guidance Published: 28 March 2018 nice.org.uk/guidance/ta516 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationScottish E. coli O157/Shiga toxin-producing E. coli Reference Laboratory
Scottish E. coli O157/Shiga toxin-producing E. coli Reference Laboratory 1 Authors: SERL68:Version L. Allison 6 Issue date & M. 27/09/2017 Hanson This is an electronic document Authors: L. Allison which
More informationThe Cancer Genome Atlas & International Cancer Genome Consortium
The Cancer Genome Atlas & International Cancer Genome Consortium Session 3 Dr Jason Wong Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 31 st July 2014 1
More informationCAP Accreditation of Genetics Testing Laboratories
CAP Accreditation of Genetics Testing Laboratories Secretary s Advisory Committee on Genetics, Health, And Society March 26, 2007 Gail Vance, MD, FCAP College of American Pathologists Overview Shared Goals
More informationGenetics update and implications for (General) Practice
Genetics update and implications for (General) Practice May 12 th 2018 Women s Health Symposium Clearwater Estate Dr Kate Gibson MB BCh, MRCP, FRACP Topics NZ Clinical Genetics delivery New Technologies
More informationCanadian College of Medical Geneticists (CCMG) Cytogenetics Examination. May 4, 2010
Canadian College of Medical Geneticists (CCMG) Cytogenetics Examination May 4, 2010 Examination Length = 3 hours Total Marks = 100 (7 questions) Total Pages = 8 (including cover sheet and 2 pages of prints)
More informationClinical Genetics Service
October 2012 Issue 1 Clinical Genetics Service Who provides your local Genetics Service? The Clinical Genetics department at Great Ormond Street Hospital (GOSH) covers a population of 4.5 million in North
More informationNational Haemoglobinopathy Reference Laboratory. Information for Users
National Haemoglobinopathy Reference Laboratory Information for Users Summary The NHRL offers a service for the identification of haemoglobinopathy genotypes by the molecular analysis of DNA and haematological
More informationPrecision Genetic Testing in Cancer Treatment and Prognosis
Precision Genetic Testing in Cancer Treatment and Prognosis Deborah Cragun, PhD, MS, CGC Genetic Counseling Graduate Program Director University of South Florida Case #1 Diana is a 47 year old cancer patient
More informationCorporate Medical Policy Genetic Testing for Breast and Ovarian Cancer
Corporate Medical Policy Genetic Testing for Breast and Ovarian Cancer File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_breast_and_ovarian_cancer 8/1997 8/2017
More informationGenetics/Genomics: role of genes in diagnosis and/risk and in personalised medicine
Genetics/Genomics: role of genes in diagnosis and/risk and in personalised medicine Lynn Greenhalgh, Macmillan Cancer and General Clinical Geneticist Cancer Genetics Service Cancer is common 1 in
More informationSingle-Gene. NGS Sequencing Throughput 1 sample 48 Samples
For immediate release Hong Kong Sanatorium & Hospital State-of-the-Art Molecular Pathology Laboratory Introduces First-in-Hong Kong Next Generation Sequencing for Clinical Diagnostic Service (8 November
More informationRisk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE
Identifying the Patient at Risk for an Inherited Syndrome Sapna Syngal, MD, MPH, FACG Director, Gastroenterology Director, Familial GI Program Dana-Farber/Brigham and Women s Cancer Center Associate Professor
More informationColonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern
Colonic polyps and colon cancer Andrew Macpherson Director of Gastroentology University of Bern Improtance of the problem of colon cancers - Epidemiology Lifetime risk 5% Incidence/10 5 /annum (US Detroit
More informationMALBAC Technology and Its Application in Non-invasive Chromosome Screening (NICS)
MALBAC Technology and Its Application in Non-invasive Chromosome Screening (NICS) The Power of One Adapted from Internet Single Cell Genomic Studies Ultra Low Sample Input Advances and applications of
More informationThe new Leeds Solid Tumour Molecular Oncology Diagnostics Service. Paul Roberts, Genetics, Leeds
The new Leeds Solid Tumour Molecular Oncology Diagnostics Service Paul Roberts, Genetics, Leeds Molecular Oncology services pre-2013 DNA lab Germline cancer Cytogenetics lab FISH, cell culture, molecular
More informationMainstreaming Cancer Genetics (MCG) Information Pack
Mainstreaming Cancer Genetics (MCG) Key Points Information Pack Genetic information is important for people with cancer and their relatives. New gene testing methods can be harnessed so that more genes
More informationOLDER PEOPLE WITH DUAL SENSORY LOSS: MEETING THEIR NEEDS. Nicola Venus-Balgobin
OLDER PEOPLE WITH DUAL SENSORY LOSS: MEETING THEIR NEEDS. Nicola Venus-Balgobin OLDER PEOPLE WITH DUAL SENSORY LOSS AWARENESS RAISING PROGRAM Funded by the Department of Health s Innovation, Excellence
More informationPatient Leader Education Summit. Precision Medicine: Today and Tomorrow March 31, 2017
Patient Leader Education Summit Precision Medicine: Today and Tomorrow March 31, 2017 Precision Medicine: Presentation Outline Agenda What is a Precision Medicine What is its clinical value Overview of
More information